JP2013513564A5 - - Google Patents

Download PDF

Info

Publication number
JP2013513564A5
JP2013513564A5 JP2012542487A JP2012542487A JP2013513564A5 JP 2013513564 A5 JP2013513564 A5 JP 2013513564A5 JP 2012542487 A JP2012542487 A JP 2012542487A JP 2012542487 A JP2012542487 A JP 2012542487A JP 2013513564 A5 JP2013513564 A5 JP 2013513564A5
Authority
JP
Japan
Prior art keywords
oxy
methyl
pyridinyl
phenyl
imidazolidinedione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012542487A
Other languages
English (en)
Japanese (ja)
Other versions
JP5788404B2 (ja
JP2013513564A (ja
Filing date
Publication date
Priority claimed from GB0921760A external-priority patent/GB0921760D0/en
Priority claimed from GBGB1012924.5A external-priority patent/GB201012924D0/en
Application filed filed Critical
Priority claimed from PCT/EP2010/068946 external-priority patent/WO2011069951A1/en
Publication of JP2013513564A publication Critical patent/JP2013513564A/ja
Publication of JP2013513564A5 publication Critical patent/JP2013513564A5/ja
Application granted granted Critical
Publication of JP5788404B2 publication Critical patent/JP5788404B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012542487A 2009-12-11 2010-12-06 イミダゾリジンジオン誘導体 Expired - Fee Related JP5788404B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0921760A GB0921760D0 (en) 2009-12-11 2009-12-11 Novel compounds
GB0921760.5 2009-12-11
GB1012924.5 2010-07-30
GBGB1012924.5A GB201012924D0 (en) 2010-07-30 2010-07-30 Novel compounds
PCT/EP2010/068946 WO2011069951A1 (en) 2009-12-11 2010-12-06 Imidazolidinedione derivatives

Publications (3)

Publication Number Publication Date
JP2013513564A JP2013513564A (ja) 2013-04-22
JP2013513564A5 true JP2013513564A5 (enExample) 2014-02-06
JP5788404B2 JP5788404B2 (ja) 2015-09-30

Family

ID=43446689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012542487A Expired - Fee Related JP5788404B2 (ja) 2009-12-11 2010-12-06 イミダゾリジンジオン誘導体

Country Status (16)

Country Link
US (7) US8722695B2 (enExample)
EP (1) EP2509961B1 (enExample)
JP (1) JP5788404B2 (enExample)
KR (1) KR101735675B1 (enExample)
CN (1) CN102753533B (enExample)
AU (1) AU2010330048B9 (enExample)
BR (1) BR112012015868A2 (enExample)
CA (1) CA2781685C (enExample)
DK (1) DK2509961T3 (enExample)
EA (1) EA019970B8 (enExample)
ES (1) ES2575215T3 (enExample)
IL (1) IL219628A (enExample)
MX (1) MX2012006615A (enExample)
PL (1) PL2509961T3 (enExample)
WO (1) WO2011069951A1 (enExample)
ZA (1) ZA201203233B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8519176B1 (en) * 2009-10-05 2013-08-27 Boehringer Ingelheim International Gmbh Process for preparation of substituted P-aminophenol
PL2509961T3 (pl) 2009-12-11 2016-09-30 Pochodne imidazolidynodionu
RS54369B1 (sr) 2010-10-08 2016-04-28 Nivalis Therapeutics, Inc. Nova jedinjenja hinolina supstituisana kao inhibitori s-nitrosoglutathione reduktaze
US9346790B2 (en) 2010-12-06 2016-05-24 Autifony Therapeutics Limited Hydantoin derivatives useful as Kv3 inhibitors
GB201209986D0 (en) 2012-06-06 2012-07-18 Autifony Therapeutics Ltd Novel compounds
JP6008953B2 (ja) * 2011-06-07 2016-10-19 アウトイフオンイ トヘラペウトイクス リミテッド Ｋｖ３阻害剤としてのヒダントイン誘導体
PL2788339T3 (pl) * 2011-12-06 2016-09-30 Pochodne hydantoiny przydatne jako inhibitory KV3
BR112014028718A2 (pt) * 2012-05-22 2017-06-27 Autifony Therapeutics Ltd derivados de hidantoína como inibidores de kv3
US9422252B2 (en) 2012-05-22 2016-08-23 Autifony Therapeutics Limited Triazoles as Kv3 inhibitors
WO2013182851A1 (en) * 2012-06-06 2013-12-12 Autifony Therapeutics Limited Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required
AU2014312756B2 (en) * 2013-08-29 2018-11-22 Kyoto Pharmaceutical Industries, Ltd. Novel aromatic compound and use thereof
DK3372585T3 (da) * 2014-12-19 2022-05-30 Aragon Pharmaceuticals Inc Fremgangsmåde til fremstillingen af en diarylthiohydantoinforbindelse
GB201521751D0 (en) * 2015-12-10 2016-01-27 Autifony Therapeutics Ltd Novel uses
CN105837453A (zh) * 2016-03-31 2016-08-10 常州大学 一种3,5-二氯-4’-硝基二苯醚的合成方法
GB201613163D0 (en) 2016-07-29 2016-09-14 Autifony Therapeutics Ltd Novel compounds
CN108101811A (zh) * 2016-11-25 2018-06-01 斯福瑞（南通）制药有限公司 生产n-叔丁氧羰基-2-氨基-3,3-二甲基丁酸的方法
US20200039970A1 (en) 2016-12-16 2020-02-06 Autifony Therapeutics Limited Hydantoin modulators of kv3 channels
WO2018204164A1 (en) 2017-05-02 2018-11-08 Fmc Corporation Pyrimidinyloxy benzo-fused compounds as herbicides
WO2018220762A1 (ja) * 2017-05-31 2018-12-06 大塚製薬株式会社 ピリミジン化合物
CA3110251A1 (en) * 2018-09-21 2019-11-28 Bionomics Limited Substituted-pyridinyl compounds and uses thereof
HRP20241318T1 (hr) 2018-10-16 2024-12-20 Autifony Therapeutics Limited Novi spojevi
US12358901B2 (en) 2018-10-16 2025-07-15 Autifony Therapeutics Limited KV3 modulators
CN113166076A (zh) 2018-11-30 2021-07-23 大塚制药株式会社 用于治疗癫痫的杂环化合物
JP6870064B2 (ja) * 2018-11-30 2021-05-12 大塚製薬株式会社 ピリミジン化合物の医薬用途
EP3947365B1 (en) * 2019-03-25 2025-10-01 Bionomics Limited Substituted-n-heteroaryl compounds and uses thereof
PH12022551955A1 (en) 2020-02-06 2023-10-23 Autifony Therapeutics Ltd Novel compound
EP3901152A1 (en) * 2020-04-23 2021-10-27 F. Hoffmann-La Roche AG Kv3 enhancers for the treatment of cognitive disorders
GB2594931A (en) * 2020-05-06 2021-11-17 Syngenta Crop Protection Ag Improvements in or relating to organic compounds
IL310160A (en) 2021-08-10 2024-03-01 Autifony Therapeutics Ltd potassium channel modulators
CN114605331A (zh) * 2022-03-17 2022-06-10 上海健康医学院 一种尼鲁米特及其中间体的制备方法
JP2025512828A (ja) * 2022-03-28 2025-04-22 バイエル・アクチエンゲゼルシヤフト 置換２－アミノアジンおよびその塩、ならびにその除草性活性物質としての使用
WO2024121552A1 (en) 2022-12-06 2024-06-13 Autifony Therapeutics Limited Compounds for the treatment of centra nervous system disorders

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1147725A (en) * 1966-03-30 1969-04-02 Mitsui Kagaku Kogyo Kabushiki Novel halodiphenylethers for use as herbicides
US4099007A (en) * 1969-04-02 1978-07-04 Hoechst Aktiengesellschaft N,n-substituted 2,4,5-triketoimidazolidines and a process for their preparation
DE2916647A1 (de) * 1979-04-25 1980-11-06 Basf Ag Parabansaeurederivate
DE3015090A1 (de) 1980-04-19 1981-10-22 Basf Ag, 6700 Ludwigshafen ]-(trihalogenmethyl-sulfenyl)-4-aryl-1,2,4-triazolidin-5-one, verfahren zu ihrer herstellung, diese enthaltende fungizide und verfahren zur bekaempfung von pilzen mit diesen verbindungen
DE3133405A1 (de) 1981-08-24 1983-03-10 Basf Ag, 6700 Ludwigshafen 1-(trihalogenmethyl-sulfenyl)-4-aryl-1,2,4-triazolidin-5-one und diese enthaltende fungizide
US4675403A (en) * 1985-10-16 1987-06-23 American Home Products Corporation 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity
JP2514945B2 (ja) 1987-02-05 1996-07-10 三井石油化学工業株式会社 芳香族アミン誘導体
DE3810848A1 (de) 1988-03-30 1989-10-19 Boehringer Ingelheim Kg Neue 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole, ihre herstellung und verwendung
DE3836175A1 (de) 1988-10-24 1990-05-03 Bayer Ag Fluor enthaltende phenole
WO1991004027A1 (en) 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
US5362878A (en) 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
US6002016A (en) * 1991-12-20 1999-12-14 Rhone-Poulenc Agrochimie Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones
FR2706456B1 (fr) * 1993-06-18 1996-06-28 Rhone Poulenc Agrochimie Dérivés optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
DK123493D0 (da) 1993-11-01 1993-11-01 Lundbeck & Co As H Compounds
MX9708802A (es) 1995-05-17 1998-02-28 Du Pont Amidas ciclicas fungicidas.
WO1996036229A1 (en) 1995-05-17 1996-11-21 E.I. Du Pont De Nemours And Company Fungicidal cyclic amides
HUP9901228A3 (en) 1995-06-20 2001-11-28 Du Pont Cyclic amides, their intermediates, arthropodicide and fungicide compositions containing theses compounds as active ingredients and use thereof
AU3889097A (en) 1996-08-01 1998-02-25 E.I. Du Pont De Nemours And Company Arthropodicidal and fungicidal cyclic amides
WO1998023155A1 (en) 1996-11-26 1998-06-04 E.I. Du Pont De Nemours And Company Arthropodicidal and fungicidal cyclic amides
JP2001506984A (ja) 1996-11-26 2001-05-29 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー メチル置換された殺菌・殺カビ剤および殺節足動物剤
WO1998033382A1 (en) 1997-01-30 1998-08-06 E.I. Du Pont De Nemours And Company Fungicidal compositions
BRPI9807848B8 (pt) * 1997-02-21 2016-05-31 Bayer Schering Pharma Ag compostos de arilsulfonamidas e análogos, bem como composição farmacêutica e uso dos mesmos.
JP4171549B2 (ja) 1998-01-28 2008-10-22 大正製薬株式会社 含フッ素アミノ酸誘導体
AR015733A1 (es) * 1998-03-25 2001-05-16 Otsuka Pharma Co Ltd DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO.
JP4194715B2 (ja) 1998-08-31 2008-12-10 大正製薬株式会社 ６−フルオロビシクロ［３．１．０］ヘキサン誘導体
JP2000072731A (ja) 1998-08-31 2000-03-07 Taisho Pharmaceut Co Ltd ４−置換−２−アミノビシクロ［３．１．０］ヘキサン−２，６−ジカルボン酸誘導体及び製薬用組成物
GB9910577D0 (en) * 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds
KR20020012309A (ko) 1999-07-23 2002-02-15 시오노 요시히코 Ｔｈ2 분화 억제제
WO2001074331A1 (en) 2000-04-04 2001-10-11 Shionogi & Co., Ltd. Oily compositions containing highly fat-soluble drugs
AU2001244610A1 (en) 2000-04-05 2001-10-23 Shionogi And Co., Ltd. Oil-in-water microemulsions containing tricyclic compounds or preconcentrates thereof
FR2812633A1 (fr) 2000-08-04 2002-02-08 Aventis Cropscience Sa Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides
GB0026838D0 (en) 2000-11-02 2000-12-20 Glaxo Group Ltd Treatment method
JPWO2003048134A1 (ja) 2001-12-05 2005-04-14 日本たばこ産業株式会社 トリアゾール化合物及びその医薬用途
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
DE60322680D1 (de) 2002-02-07 2008-09-18 Univ Missouri Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen
IL165218A0 (en) * 2002-05-16 2005-12-18 Bayer Cropscience Gmbh Pyridine carboxamide derivatives and their use as pesticides
AU2004236239A1 (en) 2003-04-30 2004-11-18 The Institutes For Pharmaceutical Discovery, Llc Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
WO2005000309A2 (en) 2003-06-27 2005-01-06 Ionix Pharmaceuticals Limited Chemical compounds
GB0325175D0 (en) 2003-10-28 2003-12-03 Novartis Ag Organic compounds
US7256208B2 (en) 2003-11-13 2007-08-14 Bristol-Myers Squibb Company Monocyclic N-Aryl hydantoin modulators of androgen receptor function
GB0413879D0 (en) 2004-06-21 2004-07-21 Glaxo Group Ltd Compounds
US20060211697A1 (en) 2004-12-08 2006-09-21 Liren Huang 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents
DE102005001411A1 (de) 2005-01-12 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
SI2351772T1 (sl) 2005-02-18 2016-11-30 Glaxosmithkline Biologicals Sa Proteini in nukleinske kisline iz Escherichia coli povezane z meningitisom/sepso
KR101782236B1 (ko) 2005-05-13 2017-09-26 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴히단토인 화합물
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
US20100113959A1 (en) 2006-03-07 2010-05-06 Beth Israel Deaconess Medical Center, Inc. Transcranial magnetic stimulation (tms) methods and apparatus
PT2368550E (pt) 2006-03-27 2013-12-03 Univ California Modulador do receptor de androgénios para o tratamento de cancro da próstata e doenças associadas ao receptor de androgénios
CN101460467B (zh) 2006-03-29 2012-09-19 加利福尼亚大学董事会 二芳基硫代乙内酰脲化合物
AU2007283113A1 (en) * 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
BRPI0807717A2 (pt) 2007-04-20 2014-05-20 Deciphera Pharmaceuticals Llc Inibidores de quinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas.
WO2009097997A1 (de) * 2008-02-07 2009-08-13 Sanofi-Aventis Substituierte imidazolidin-2,4-dione, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
EP2252592A1 (de) 2008-02-07 2010-11-24 Sanofi-Aventis Arylchalcogeno-arylalkyl-substituierte imidazolidin-2,4-dione, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
WO2010027818A2 (en) 2008-08-25 2010-03-11 Dana-Farber Cancer Institute, Inc. Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use
BRPI0924121A2 (pt) 2008-12-22 2019-09-24 Hoffmann La Roche compostos antivirais heterocíclicos
WO2010149765A1 (en) 2009-06-26 2010-12-29 Inserm (Institut National De La Sante Et De La Recherche Medicale) Non human animal models for increased retinal vascular permeability
PL2509961T3 (pl) * 2009-12-11 2016-09-30 Pochodne imidazolidynodionu
CA2780526A1 (en) 2009-12-14 2011-06-23 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
US9346790B2 (en) * 2010-12-06 2016-05-24 Autifony Therapeutics Limited Hydantoin derivatives useful as Kv3 inhibitors
US8648118B2 (en) 2010-12-17 2014-02-11 Boehringer Ingelheim International Gmbh Bicyclic ring system substituted amide functionalised phenols as medicaments
US8648070B2 (en) 2010-12-17 2014-02-11 Boehringer Ingelheim International Gmbh Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
JP6008953B2 (ja) * 2011-06-07 2016-10-19 アウトイフオンイ トヘラペウトイクス リミテッド Ｋｖ３阻害剤としてのヒダントイン誘導体
BR112014028718A2 (pt) 2012-05-22 2017-06-27 Autifony Therapeutics Ltd derivados de hidantoína como inibidores de kv3
US9422252B2 (en) * 2012-05-22 2016-08-23 Autifony Therapeutics Limited Triazoles as Kv3 inhibitors

Similar Documents

Publication Publication Date Title
JP2013513564A5 (enExample)
JP6218808B2 (ja) Ｌｒｒｋ２モジュレ−タ−としてのピラゾ−ルアミノピリミジン誘導体
JP5572675B2 (ja) βセクレターゼ阻害作用を有する含硫黄複素環誘導体
RU2412937C2 (ru) Соединения трехзамещенного амина и их применение в качестве ингибиторов белка переноса холестерилового эфира (сетр)
RU2634716C2 (ru) Производные аминопиридина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2)
US10308659B2 (en) Pyridine derivatives
KR101867110B1 (ko) 트라이아진 유도체 및 그것을 함유하는 진통 작용을 갖는 의약 조성물
US10787458B2 (en) Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines
US10358435B2 (en) Triazolyl pyrimidinone compounds as PDE2 inhibitors
ES2976515T3 (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad del receptor APJ
US20100087460A1 (en) Arylamide pyrimidone derivatives
US20180134712A1 (en) 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors
US20240083896A1 (en) Nitrogen Containing 2,3-Dihydroquinazolinone Compounds as Nav1.8 Inhibitors
US9815796B2 (en) Pyrimidone carboxamide compounds as PDE2 inhibitors
US10195201B2 (en) Heteroaryl-pyrimidinone compounds as PDE2 inhibitors
US20250304546A1 (en) Compounds for the treatment of a central nervous system disease or disorder
US20250243173A1 (en) Compounds for the treatment of a central nervous system disease or disorder
US20250236602A1 (en) Compounds for the treatment of a central nervous system disease or disorder
US20250388558A1 (en) Compounds for the treatment of a central nervous system disease or disorder
US20250129035A1 (en) Compounds for the treatment of a central nervous system disease or disorder
EP4085054B1 (en) New pqsr inverse agonists
HK40002908B (zh) [1，2，3]三唑并[4，5-d]嘧啶衍生物
HK40002908A (en) Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives